EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal Single‐Cell Transcriptomic Profiling Reveals Dynamic Immune Cell Alterations During Burosumab Therapy in X‐Linked Hypophosphatemia

Yue Xie, Li Li, Rong Li, Yihong Sun, Ting Zhou, Yupeng Cun, Gaohui Zhu

Pediatric Discovery · 2026-06 · 4 (2)

DOI: 10.1002/pdi3.70053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Discovery, online erschienen am 27.06.2026. Verfasst von Yue Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders Pediatric Research Institute, Children's Hospital of Chongqing Medical Uni…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X‐linked hypophosphatemia (XLH) is a rare hereditary disorder characterized by PHEX gene mutations, elevated FGF23 levels, and impaired bone mineralization. Burosumab, a monoclonal antibody targeting FGF23 , has demonstrated clinical efficacy; however, the immunological dynamics during treatment remain unexplored. This study employed longitudinal single‐cell RNA sequencing (scRNA‐seq) to characterize peripheral blood immune cell alterations across multiple treatment stages in pediatric XLH. We performed scRNA‐seq on peripheral blood mononuclear cells from pediatric patients with XLH at five time points spanning pretreatment and burosumab therapy phases, along with healthy pediatric controls. A total of 93,112 cells were analyzed using comprehensive bioinformatic pipelines, including unsupervised clustering, pseudotime trajectory analysis, temporal gene expression profiling, and cell–cell communication inference. Eleven major immune cell populations were identified, with notable dynamic alterations in T cells and natural killer (NK) cell subtypes across treatment stages. The cellular proportion of T helper 2 (Th2) cells and regulatory T (Treg) cells were elevated before treatment and normalized during therapy, whereas T helper 17 (Th17) cells exhibited reciprocal patterns. Genes upregulated in Treg cells during early treatment were enriched in osteoclast differentiation pathway. Natural killer subtype 2 cells showed enrichment in osteoclast differentiation and interleukin‐12 response pathways. Cell–cell communication analysis identified dynamic interactions among Th2 cells, Th17 cells, Treg cells, and NK cell subtypes mediated by KLRB1–CLEC2D and SELL–SELPLG ligand‐receptor pairs. This longitudinal transcriptomic study provides the first comprehensive characterization of peripheral immune dynamics during burosumab therapy in XLH, offering new insights into the immunological mechanisms underlying treatment response.

Schlagwörter

Stichwörter der Autor:innen

BurosumabX‐linked hypophosphatemialongitudinal studyosteoclast differentiationsingle‐cell RNA sequencing

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders Pediatric Research Institute, Children's Hospital of Chongqing Medical University Chongqing China.
  • Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders Children's Hospital of Chongqing Medical University Chongqing China.
  • Department of Endocrinology, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity Children's Hospital of Chongqing Medical University Chongqing China.

Zitieren

APA

Xie, Y., Li, L., Li, R., Sun, Y., Zhou, T., Cun, Y., & Zhu, G. (2026). Longitudinal Single‐Cell Transcriptomic Profiling Reveals Dynamic Immune Cell Alterations During Burosumab Therapy in X‐Linked Hypophosphatemia. Pediatric Discovery, 4(2). https://doi.org/10.1002/pdi3.70053

Vancouver

Xie Y, Li L, Li R, Sun Y, Zhou T, Cun Y, et al. Longitudinal Single‐Cell Transcriptomic Profiling Reveals Dynamic Immune Cell Alterations During Burosumab Therapy in X‐Linked Hypophosphatemia. Pediatric Discovery. 2026;4(2). doi:10.1002/pdi3.70053

BibTeX
@article{Xie2026,
  author = {Xie, Yue and Li, Li and Li, Rong and Sun, Yihong and Zhou, Ting and Cun, Yupeng and Zhu, Gaohui},
  title = {Longitudinal Single‐Cell Transcriptomic Profiling Reveals Dynamic Immune Cell Alterations During Burosumab Therapy in X‐Linked Hypophosphatemia},
  journal = {Pediatric Discovery},
  year = {2026},
  volume = {4},
  number = {2},
  doi = {10.1002/pdi3.70053}
}
Kostenlos starten →